About
MDG

Medgaea Life Sciences is a third party laboratory that is certificated for OECD GLP, TFDA GLP, ISO 17025 and ISO 9001. Maily based on preclinical CRO, we provide total-soltion services to assist biotechnology industries successfully obtain the product certification and exploit internation market.

view more

 

CRO

  • check

    Needs Discuss

  • check

    Quote and Ordar

  • check

    Timetable Schedule

  • check

    Report Launch

  • done

    Case Closed

view more

Services

With devoting to our core value 『Honesty•Accuracy•Professionalism•Responsibility』,

We have successfully assisted our customers to successfully obtain the product certification in FDA, CE, TFDA and NMPA.

Medical Devices

One of the first priority of medical devices R&D is their safety. The Biocompatibility test is mainly followed the ISO 10993 international standard.

Cell therapy and Regenerative medicine

We assist the safety, effectiveness tests during the R&D process of cell therapy product. All the tests are complied with GLP.

Pharmaceutical development

As the agent of SNBL in Taiwan, will help new drugs company to complete non-clinical trials in medium, large animals and primates in the research and development stage.

Agrochemical and Enviromental Agents

The agroculture products need to review their toxicological data in advance, and all the tests must be carried out in complies with GLP.

Chemical Substances

Providing the toxicological test information!
EPA acquired the test information as the core basis to evaluate the substance announcement.

Health Food/ Ingredients

Provide safety, efficacy and stability tests for food ingredients and health foods.

Registration

Provide registration services.

Pharmaceuticals

Provide batch examine for medicine release, including pyrogen, acute systemic toxicity and other tests.

Laboratory animals and Equipment

An agent and supplier based on research and development of animal experiments, providing import services for various disease model animals in research institutions.

| 發布日期:2026-01-27 | 維護日期:2026-01-27

 

發文日期:中華民國115年1月27日
發文字號:衛授食字第1141303221號

 

訂定「新興食品原料安全性評估作業原則」,並自即日生效。

 

 附「新興食品原料安全性評估作業原則」

 

 

檔案下載
衛授食字第1141303221號令
新興食品原料安全性評估作業原則(全文含附件) (115.1.27發布)

新興食品原料安全性評估作業原則(本文) (115.1.27發布)

附件一、判定是否為新興食品原料之問卷(115.1.27發布)

附件二、新興食品原料安全性評估資料表 (115.1.27發布)

附件三、以基因改造微生物生產但最終不含該微生物及轉殖基因之相關產品應備資料 (115.1.27發布)